Breakthrough in understanding of how cancer treatment drugs affect cells

January 14, 2013 in Cancer

(Medical Xpress)—A young Victoria University scientist is part of a team whose work has been published in the prestigious international magazine Science, for research that will open doors to developing much more effective cancer treatment drugs.

Jessica Field, who is due to complete her PhD late in the year, won a highly-sought after European scholarship to allow her to study in Madrid, where she joined a research team led by Dr José Fernando Díaz of the Centro de Investigaciones Biológicas, Madrid, Spain.

The team made the ground-breaking discovery of proving how some existing cancer treatment drugs really work in , by obtaining a high resolution X-ray of the . The research shows a much more exact understanding of how the drugs fight cancer cells.

"In the past, we have used these drugs, understanding their general effect on cancer cells—but without intricately knowing exactly how they work," says Jessica.

The new research means that in the future, scientists all over the world will be better equipped to develop more targeted cancer treatment drugs, with improved capability and fewer side effects.

Professor John Miller, from Victoria University's School of , says he is very proud of Jessica's achievements.

"The research itself is incredible, and has the potential to change the face of in the future. The very fact that it has been published in such a highly regarded publication is testament to its importance, and testament to the brilliant work that Jessica and our colleagues have done."

Earlier in her studies, Jessica made a remarkable discovery when she was asked to take a compound that had not been previously investigated and find out what it does.

She found that the compound, called Zampanolide, has the ability to prevent cancer cells from dividing, which could stop the spread of cancer. But one of its most remarkable functions is the way that it works within the cancer cell.

"The major problem with a cancer drug is that over time, cancer cells can find a way to oust the drug, becoming resistant to the medication," Jessica explains. "Because of the way this new compound interacts with cancer cells, it cannot be removed from the cell, so they can't become resistant to the drug by this mechanism."

Zampanolide was initially isolated by Victoria University's Associate Professor Peter Northcote, from sea sponges found in Tonga, but can now be made synthetically. This, says Jessica, is a major benefit.

"In the past, to find Zampanolide, we would have to individually screen marine sponges for its presence. Now, we can make it in the quantities we require."

Journal reference: Science search and more info website

Provided by Victoria University search and more info website

5 /5 (2 votes)  

Rank 5 /5 (2 votes)
Relevant PhysicsForums posts

More news stories

Small cancer risk following CT scans in childhood and adolescence confirmed

The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...

Cancer created 8 hours ago | popularity not rated yet | comments 0

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

Cancer created 9 hours ago | popularity not rated yet | comments 0

Novel RNA-based classification system for colorectal cancer

A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine this w ...

Cancer created 9 hours ago | popularity not rated yet | comments 0

Low radiation scans help identify cancer in earliest stages

A study of veterans at high risk for developing lung cancer shows that low-dose computed tomography (LDCT) can be highly effective in helping clinicians spot tiny lung nodules which, in a small number of patients, may indicate ...

Cancer created 11 hours ago | popularity not rated yet | comments 0

Poliovirus vaccine trial shows early promise for recurrent glioblastoma

An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.

Cancer created 13 hours ago | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.